Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...

Cardiomyopathy IV: Restrictive Cardiomyopathy

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Density-aware active learning for materials discovery: a case study on functionalized nanoporous materials.

Physical chemistry chemical physics : PCCP·2025

Same author

Attention Deficit/Hyperactivity Disorder (ADHD) symptoms and cognitive skills of preschool children.

Psychiatrike = Psychiatriki·2017

Same author

Job insecurity, financial difficulties and mental health in Europe.

Occupational medicine (Oxford, England)·2016

Same author

Comorbid psychopathology and clinical symptomatology in children and adolescents with obsessive-compulsive disorder.

Psychiatrike = Psychiatriki·2016

Same author

[Coronary artery disease: diagnostic approach in 2013].

Revue medicale suisse·2013

Same author

Coronary artery-middle cardiac vein fistula after endomyocardial biopsy in a heart transplant patient.

The Canadian journal of cardiology·2009

Search research articles

Related Experiment Video

Updated: May 12, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

[Hypertrophic cardiomyopathy in 2013].

G Giannakopoulos¹, C Frangos

¹Centre de cardiologie non invasive, Hôpital de la Tour, Avenue J.-D. Maillard Ibis, 1217 Meyrin. georgios.giannakopoulos@latour.ch

Revue Medicale Suisse

|March 29, 2013

Summary

Hypertrophic cardiomyopathy, a genetic heart condition, presents varied symptoms and outcomes. Identifying high-risk patients for preventative treatment remains a complex challenge.

Area of Science:

Cardiology
Genetics
Molecular Biology

Context:

Hypertrophic cardiomyopathy (HCM) is the most prevalent genetic heart disease.
It stems from mutations in genes responsible for sarcomeric proteins.
HCM exhibits diverse clinical presentations and disease progression.

Purpose:

To summarize the complexities of hypertrophic cardiomyopathy.
To highlight challenges in risk stratification and treatment.

Summary:

HCM's genetic basis involves sarcomeric protein mutations, leading to heterogeneous clinical courses.
Sudden cardiac death is a rare but unpredictable complication, especially in young individuals.
Identifying patients for primary prevention with implantable cardioverter-defibrillators is challenging.

More Related Videos

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Related Experiment Videos

Last Updated: May 12, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Impact:

Improved understanding of HCM genetics and clinical heterogeneity.
Potential for enhanced risk stratification strategies.
Informs therapeutic decisions for symptomatic obstruction, including myectomy and ablation.